TrueBlue Q4 revenue rises 8%, but net loss widens

Reuters
Feb 19
<a href="https://laohu8.com/S/TBI">TrueBlue</a> Q4 revenue rises 8%, but net loss widens

Overview

  • Workforce solutions provider's Q4 revenue grew 8% yr/yr

  • Adjusted EPS for Q4 missed analyst expectations

  • Company's net loss widened due to non-cash impairment charge

Outlook

  • TrueBlue did not provide specific guidance in the press release

Result Drivers

  • ORGANIC GROWTH - TrueBlue's Q4 revenue growth was driven by momentum in skilled businesses and stability in demand trends, per CEO Taryn Owen

  • ACQUISITION CONTRIBUTION - Revenue included $14 mln from the acquisition of Healthcare Staffing Professionals

  • SG&A IMPROVEMENT - SG&A expenses improved by 11% compared to the prior year period

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Beat

$418 mln

$413.36 mln (1 Analyst)

Q4 Adjusted EPS

Miss

-$0.25

-$0.05 (3 Analysts)

Q4 Net Income

-$32 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the employment services peer group is "buy"

  • Wall Street's median 12-month price target for TrueBlue Inc is $8.50, about 92.3% above its February 17 closing price of $4.42

  • The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 22 three months ago

Press Release: ID:nBw27H55sa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10